Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S5 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001
  1. Home
  2. Publications
  3. Supplementary Table S5 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001

Supplementary Table S5 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001

Authors:
  • YZYan Zhou
    Yan Zhou
  • QYQingcheng Yang
    Qingcheng Yang
  • YDYang Dong
    Yang Dong
  • TJTong Ji
    Tong Ji
  • BZBing Zhang
    Bing Zhang
  • CYCheng Yang
    Cheng Yang
  • SZShuier Zheng
    Shuier Zheng
  • LTLina Tang
    Lina Tang
  • CZChenliang Zhou
    Chenliang Zhou
  • GQGuowei Qian
    Guowei Qian
  • YHYujing Huang
    Yujing Huang
  • WYWenxi Yu
    Wenxi Yu

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30705891
Abstract
Representativeness of study participants
Keywords
  • CHEMOTHERAPY
  • CLINICAL-STAGE RESEARCH
  • SARCOMAS
  • OSTEOSARCOMA
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.